Zoetis Inc.

XETRA:ZOE.DE

$177.3 EUR

-$7.7 (-4.16%)

Volume
164
Average Volume
101
Market Capitalization
$81.18B
P/E Ratio
37.96
Dividend Yield
0.81%
Price Target
$
Year High
$185.00
Year Low
$142.50
Payout Ratio
$0.30
Current Ratio
$3.36

Industry, Sector & symbol

Stock Exchange Frankfurt Stock Exchange
CEO Ms. Kristin C. Peck
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol ZOE.DE
CUSIP None
CIK None
Web https://www.zoetis.com
Phone 973 822 7000
Currency EUR
Employees 14100
Country US

Liquidity

Debt-to-Equity Ratio 1.35
Payout Ratio 0.30
Current Ratio 3.36
Quick Ratio 1.77
Cash Ratio 1.08

Sales & Book Value

Annual Sales $8.54B
Price / Sales 10.30
Cash Flow 3.50
Price / Cash Flow 54.28
Price / Book 17.80

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Strong Buy
Rating Score(0-5) 5
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $5.07
Trailing P/E Ratio 37.96
PEG Ratio 4.27
P/E Growth 4.27
Net Income $2.34B
Net Margin 27.43%
Pretax Margin 34.36%
Return on Equity 48.85%
Return on Assets 16.41%

Financials Score

AltmanZ Score 7.97
Piotroski Score 7.00
Working Capital 4.45B
Total Assets 14.29B
Ebit 3.25B
Market Cap 81.18B
Total Liabilities 9.3B

Poll Results

About Zoetis Inc. (XETRA:ZOE.DE) Stock

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise ... pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Frequently Asked Questions

What is the current Zoetis Inc. (ZOE.DE) stock price?

Zoetis Inc.(XETRA:ZOE.DE) stock price is $177.3 in the last trading session. During the trading session, ZOE.DE stock reached the peak price of $185.0 while $142.5 was the lowest point it dropped to. The percentage change in ZOE.DE stock occurred in the recent session was --4.16% while the dollar amount for the price change in ZOE.DE stock was -$-7.7.

ZOE.DE's industry and sector of operation?

The XETRA listed ZOE.DE is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of ZOE.DE?

Ms. Jeannette Ferran Astorga | Executive Vice President of Corporate Affairs & Communications and Chief Sustainability Officer
Ms. Wafaa Mamilli | EVice President, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health
Dr. Robert J. Polzer Ph.D. | Executive Vice President and President of Research & Development
Mr. Wetteny N. Joseph | Executive Vice President & Chief Financial Officer
Ms. Heidi C. Chen | Executive Vice President, General Counsel, Corporate Secretary & Business Lead of Human Health Diagnostics

How many employees does ZOE.DE have?

Number of ZOE.DE employees currently stands at 14100. ZOE.DE operates from 10 Sylvan Way, Parsippany, NJ 07054, US.

Link for ZOE.DE official website?

Official Website of ZOE.DE is: https://www.zoetis.com

How do I contact ZOE.DE?

ZOE.DE could be contacted at phone #973 822 7000 and can also be accessed through its website. ZOE.DE operates from 10 Sylvan Way, Parsippany, NJ 07054, US.

How many shares of ZOE.DE are traded daily?

The average number of ZOE.DE shares traded daily for last 3 months was 101.

What is the market cap of ZOE.DE currently?

The market value of ZOE.DE currently stands at $81.18B with its latest stock price at $177.3